Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes (original ) (raw )Kinetic, Stability, and Structural Changes in High-resolution Crystal Structures of HIV-1 Protease with Drug-resistant Mutations L24I, I50V, and G73S
Yuan-fang Wang , Irene Weber
Journal of Molecular Biology, 2005
View PDFchevron_right
Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 A resolution crystal structures of HIV-1 protease mutants with substrate analogs
Yuan-fang Wang , Irene Weber
FEBS Journal, 2005
View PDFchevron_right
Inhibitor binding at the protein interface in crystals of a HIV1 protease complex
Renata Collard , Jiří Brynda
Acta Crystallographica Section D-biological Crystallography, 2004
View PDFchevron_right
Substrate shape determines specificity of recognition for HIV1 protease: analysis of crystal structures of six substrate complexes
Moses Prabu
2002
View PDFchevron_right
Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs
Lin Hong
Febs Letters, 1997
View PDFchevron_right
Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs1
Stephen Foundling
FEBS letters, 1997
View PDFchevron_right
The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations
Michael Minnich
Journal of Biological Chemistry, 1994
View PDFchevron_right
Crystal structure of HIV-1 protease in situ product complex and observation of a low-barrier hydrogen bond between catalytic aspartates
Amit Das
Proceedings of the National Academy of Sciences, 2006
View PDFchevron_right
Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy
Peter Domaille
Protein Science, 2008
View PDFchevron_right
Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir
Irene Weber , Yuan-fang Wang
Proteins: Structure, Function, and Bioinformatics, 2007
View PDFchevron_right
Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Human Immunodeficiency Virus Type 1 Protease
Tim Jonckers
Journal of Virology, 2007
View PDFchevron_right
Structural and kinetic analysis of drug resistant mutants of HIV-1 protease
Yuan-fang Wang , Irene Weber
European Journal of Biochemistry, 1999
View PDFchevron_right
Caught in the Act: The 1.5 Å Resolution Crystal Structures of the HIV-1 Protease and the I54V Mutant Reveal a Tetrahedral Reaction Intermediate †
Irene Weber
Biochemistry, 2007
View PDFchevron_right
Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site
Yuan-fang Wang , Irene Weber
European Journal of Biochemistry, 2004
View PDFchevron_right
Analysis of the HIV-2 protease’s adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet
Anne-claude Camproux
Scientific Reports
View PDFchevron_right
Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
Robert Harrison
Journal of Molecular Biology, 2006
View PDFchevron_right
Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV1 protease dimer/saquinavir complex
Subhash Bihani
Biochemical and Biophysical Research Communications, 2010
View PDFchevron_right
Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling
Stephen Foundling
Protein …, 1992
View PDFchevron_right
Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule
Bruce Aungst
Drug Discovery Today, 1997
View PDFchevron_right
Conformational variation of an extreme drug resistant mutant of HIV protease
Robert Harrison
Journal of molecular graphics & modelling, 2015
View PDFchevron_right
Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants
Krishnan Ramanathan
International Journal of Biological Macromolecules, 2008
View PDFchevron_right
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains
Yuan-fang Wang , Irene Weber
Journal of Molecular Biology, 2004
View PDFchevron_right
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures
Chris Tantillo
Proceedings of the National Academy of Sciences, 1993
View PDFchevron_right
Mechanism of Substrate Recognition by Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variants Revealed by a Novel Structural Intermediate
Moses Prabu
Journal of Virology, 2006
View PDFchevron_right
Rational Design, Synthesis, and Crystallographic Analysis of a Hydroxyethylene-Based HIV-1 Protease Inhibitor Containing a Heterocyclic P1'-P2' Amide Bond Isostere
Thomas Meek
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Structure of HOE/BAY 793 Complexed to Human Immunodeficiency Virus (HIV-1) Protease in Two Different Crystal Forms Structure/Function Relationship and Influence of Crystal Packing
Juraj Sedláček , Jochen Knolle
European Journal of Biochemistry, 1997
View PDFchevron_right
Defective Hydrophobic Sliding Mechanism and Active Site Expansion in HIV-1 Protease Drug Resistant Variant Gly48Thr/Leu89Met: Mechanisms for the Loss of Saquinavir Binding Potency
David Ostrov , Nathan Goldfarb
Biochemistry, 2015
View PDFchevron_right